Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: Immune system evasion, distance tumor metastases, and increased cell proliferation are the main reasons for the progression of non-small cell lung cancer (NSCLC) and the death of NSCLC patients. Dysregulation of circular RNAs plays a critical role in the progression of NSCLC; therefore, further understanding the biological mechanisms of abnormally expressed circRNAs is critical to discovering novel, promising therapeutic targets for NSCLC treatment. Methods: The expression of circular RNA fibroblast growth factor receptor 1 (circFGFR1) in NSCLC tissues, paired nontumor tissues, and cell lines was detected by RT-qPCR. The role of circFGFR1 in NSCLC progression was assessed both in vitro by CCK-8, clonal formation, wound healing, and Matrigel Transwell assays and in vivo by a subcutaneous tumor mouse assay. In vivo circRNA precipitation, RNA immunoprecipitation, and luciferase reporter assays were performed to explore the interaction between circFGFR1 and miR-381-3p. Results: Here, we report that circFGFR1 is upregulated in NSCLC tissues, and circFGFR1 expression is associated with deleterious clinicopathological characteristics and poor prognoses for NSCLC patients. Forced circFGFR1 expression promoted the migration, invasion, proliferation, and immune evasion of NSCLC cells. Mechanistically, circFGFR1 could directly interact with miR-381-3p and subsequently act as a miRNA sponge to upregulate the expression of the miR-381-3p target gene C-X-C motif chemokine receptor 4 (CXCR4), which promoted NSCLC progression and resistance to anti-programmed cell death 1 (PD-1)- based therapy. Conclusion: Taken together, our results suggest the critical role of circFGFR1 in the proliferation, migration, invasion, and immune evasion abilities of NSCLC cells and provide a new perspective on circRNAs during NSCLC progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · cited 1×
“Circular RNAs (circRNAs) are a class of noncoding RNAs or protein-coding RNAs derived from a single exon or multiple exons and are located in the cytoplasm [5, 6].”
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Horn, L., Spigel, D. R., Vokes, E. E., Holgado, E., Ready, N., Steins, M., Poddubskaya, E., Borghaei, H., Felip, E., Paz-Ares, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.3062 · Cited by 861
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
Yu, J., Xu, Q.-G., Wang, Z.-G., Yang, Y., Zhang, L., Ma, J.-Z., Sun, S.-H., Yang, F., & Zhou, W.-P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.012 · Cited by 765
Exosomal circRNAs: biogenesis, effect and application in human diseases
Wang, Y., Liu, J., Ma, J., Sun, T., Zhou, Q., Wang, W., Wang, G., Wu, P., Wang, H., Jiang, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1041-z · Cited by 636
Su, M., Xiao, Y., Ma, J., Tang, Y., Tian, B., Zhang, Y., Li, X., Wu, Z., Yang, D., Zhou, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1002-6 · Cited by 457
A Neutrophil Timer Coordinates Immune Defense and Vascular Protection
Adrover, J. M., del Fresno, C., Crainiciuc, G., Cuartero, M. I., Casanova-Acebes, M., Weiss, L. A., Huerga-Encabo, H., Silvestre-Roig, C., Rossaint, J., Cossío, I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.002 · Cited by 445
Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815515116 · Cited by 406 · cited 1×
“CXCR4 is a potential mediator that induces cytotoxic Tlymphocyte exclusion and participates in resistance to anti-PD-1 therapy of cancer [30, 31].”
Wang, L., Long, H., Zheng, Q., Bo, X., Xiao, X., & Li, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1046-7 · Cited by 380
Anagnostou, V., Forde, P. M., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Sivakumar, I. K. A., Bruhm, D. C., Rosner, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1127 · Cited by 318
CircNT5E Acts as a Sponge of miR-422a to Promote Glioblastoma Tumorigenesis
Wang, R., Zhang, S., Chen, X., Li, N., Li, J., Jia, R., Pan, Y., & Liang, H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0532 · Cited by 298
Pearson, A., Smyth, E., Babina, I. S., Herrera-Abreu, M. T., Tarazona, N., Peckitt, C., Kilgour, E., Smith, N. R., Geh, C., Rooney, C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1246 · Cited by 276
Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus
Zhao, J., Lee, E. E., Kim, J., Yang, R., Chamseddin, B., Ni, C., Gusho, E., Xie, Y., Chiang, C.-M., Buszczak, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10246-5 · Cited by 276
Herbst, R. S., Arkenau, H.-T., Santana-Davila, R., Calvo, E., Paz-Ares, L., Cassier, P. A., Bendell, J., Penel, N., Krebs, M. G., Martin-Liberal, J., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30458-9 · Cited by 270
Chen, L., Nan, A., Zhang, N., Jia, Y., Li, X., Ling, Y., Dai, J., Zhang, S., Yang, Q., Yi, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0943-0 · Cited by 261
Wu, Y., Xie, Z., Chen, J., Chen, J., Ni, W., Ma, Y., Huang, K., Wang, G., Wang, J., Ma, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1007-1 · Cited by 260
Zhang, P.-F., Wei, C.-Y., Huang, X.-Y., Peng, R., Yang, X., Lu, J.-C., Zhang, C., Gao, C., Cai, J.-B., Gao, P.-T., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1031-1 · Cited by 238
Self-citationSeo, Y. D., Jiang, X., Sullivan, K. M., Jalikis, F. G., Smythe, K. S., Abbasi, A., Vignali, M., Park, J. O., Daniel, S. K., Pollack, S. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0081 · Cited by 227
FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
Heist, R. S., Mino-Kenudson, M., Sequist, L. V., Tammireddy, S., Morrissey, L., Christiani, D. C., Engelman, J. A., & Iafrate, A. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aed28 · Cited by 204
Functional role of circular RNAs in cancer development and progression
Ng, W. L., Mohd Mohidin, T. B., & Shukla, K. (2018) · RNA Biology · doi:10.1080/15476286.2018.1486659 · Cited by 187
Wang, K., Ji, W., Yu, Y., Li, Z., Niu, X., Xia, W., & Lu, S. (2018) · Oncogene · doi:10.1038/s41388-018-0311-3 · Cited by 169
Wei, C.-Y., Zhu, M.-X., Yang, Y.-W., Zhang, P.-F., Yang, X., Peng, R., Gao, C., Lu, J.-C., Wang, L., Deng, X.-Y., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0711-z · Cited by 161
Self-citationSu, S., Dong, Z., Xie, Z., Yan, L., Li, Y., Su, J., Liu, S. M., Yin, K., Chen, R., Huang, S., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.07.016 · Cited by 151
Self-citationZhang, J., Hou, L., Liang, R., Chen, X., Zhang, R., Chen, W., & Zhu, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1015-1 · Cited by 133
Schultheis, A. M., Bos, M. C. A., Schmitz, K., Wilsberg, L., Binot, E., Wolf, J., Büttner, R., & Schildhaus, H. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.141 · Cited by 108
FGFR1 Is Essential for Prostate Cancer Progression and Metastasis
Yang, F., Zhang, Y., Ressler, S. J., Ittmann, M., Ayala, G. E., Dang, T. D., Wang, F., & Rowley, D. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3274 · Cited by 108
Self-citationCircRNAs and lung cancer: Biomarkers and master regulators
Di, X., Jin, X., Li, R., Zhao, M., & Wang, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.055 · Cited by 95
Progress in research on the role of circular RNAs in lung cancer
Chen, Y., Wei, S., Wang, X., Zhu, X., & Han, S. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1515-2 · Cited by 73
Qiu, B., Zhang, P., Xiong, D., Xu, J., Long, X., Zhu, S., Ye, X., Wu, Y., Pei, X., Zhang, X., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27783 · Cited by 73
Self-citationYang, X. Y., Ruan, H., Hu, X., Anyi, C., & Li, S. (2017) · PubMed Central · Cited by 69
miR‐381‐3p restrains cervical cancer progression by downregulating FGF7
Shang, A., Zhou, C., Bian, G., Chen, W., Lu, W., Wang, W., & Li, D. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27438 · Cited by 65
FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
Carstens, J. L., Shahi, P., Van Tsang, S., Smith, B., Creighton, C. J., Zhang, Y., Seamans, A., Seethammagari, M., Vedula, I., Levitt, J. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1093 · Cited by 43
Liang, T., Wang, B., Li, J., & Liu, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.916327 · Cited by 42
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer
Melosky, B. L., Juergens, R. A., McLeod, D., Leighl, N. B., Brade, A. M., Card, P. B., & Chu, Q. S.-C. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.05.027 · Cited by 35
Zheng, C., Chen, X., Zhang, F., Zhao, C. L., & Tu, S. (2018) · Cell Biology International · doi:10.1002/cbin.11024 · Cited by 30
Zhang, R., Dong, Y., Sun, M., Wang, Y., Cai, C., Zeng, Y., Wu, Y., & Zhao, Q. (2019) · Journal of Cancer · doi:10.7150/jca.26277 · Cited by 27
Xie, F., Lu, H., Zheng, Q., Jin, Q., Gao, Y., Zhang, Y., Hu, X., & Mao, W. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s91848 · Cited by 24
Saba, N. F., Wang, Y., Fu, H., Koenig, L., Khuri, F. R., Shin, D. M., & Chen, Z. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.12.005 · Cited by 17
Wei, C., Zhu, M.-X., Zhang, P.-F., Yang, X., Wang, L., Ying, J., Luan, W., Chen, C., Liu, J.-Q., Ming, Z., et al. (2019) · Aging · doi:10.18632/aging.102187 · Cited by 17
Self-citationYang, M., Yu, X., Li, X., Luo, B., Yang, W., Lin, Y., Li, D., Gan, Z., Xu, J., & He, T. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1024-9 · Cited by 15
Tseng, D., Padda, S. K., & Wakelee, H. A. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.04.008 · Cited by 7
Cited by
The emerging roles of circRNAs in cancer and oncology
Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00585-y · Cited by 1,256
Zhang, P.-F., Gao, C., Huang, X.-Y., Lu, J.-C., Guo, X.-J., Shi, G.-M., Cai, J.-B., & Ke, A.-W. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01222-5 · Cited by 593
Self-citationCircRNA in cancer: Fundamental mechanism and clinical potential
Chen, L., & Shan, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.004 · Cited by 535
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Review on circular RNAs and new insights into their roles in cancer
Tang, X., Ren, H., Guo, M., Qian, J., Yang, Y., & Gu, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.018 · Cited by 358
Metadata
- Authors
- Zhang, P.-F., Pei, X., Li, K.-S., Jin, L.-N., Wang, F., Wu, J., & Zhang, X.-M.
- Venue
- Molecular Cancer
- Published
- 2019-12
- Volume
- 18
- Issue
- 1
- Pages
- 179-179
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2995976087
- Cited by
- 253
- References
- 42
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.